Healthcare

Investment Banking

Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.

Sub-Sectors in Focus

Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.

  • Pharmaceuticals - generics/specialty generics, specialty pharmaceuticals, API / CDMO / CRO
  • Healthcare delivery - hospitals, diagnostics, single specialty
  • Medical technology - lifesciences, medical devices, consumables

Led By

Chintan Kothari

Executive Director and Head, Healthcare, Avendus Capital

Chintan Kothari leads the Healthcare vertical for Avendus's investment banking business and is based in Mumbai.

He has an overall 15 years of experience in investment banking where he led healthcare and consumer vertical for Citigroup and prior to that for Rothschild India. Chintan has extensive transaction experience aggregating over USD 10 billion across pharmaceuticals (generics, injectables, branded generics, API and animal health) and healthcare sub-sectors (hospitals, diagnostics and single specialty). This covers a broad spectrum of transactions including both private and public markets. He has advised several large corporates including Pfizer, Sun Pharma, Lupin, Hindustan Unilever, United Spirits, Apollo Hospitals, Fortis, Dr. Lal Pathlabs, Metropolis as well as multiple mid-market family-owned businesses and several global private equity (PE) funds.

Chintan holds an MBA degree from Case Western Reserve University, USA and a Bachelor of Commerce degree from Sydenham College, Mumbai. He is a CFA charter holder.

Transactions

Jul 2020

Value : Undisclosed

Avendus Capital advises the Promoters of J.B. Chemicals & Pharmaceuticals on the sale of a controlling stake to KKR
Jul 2020

Value : USD 220 million

Avendus Capital advises Ascent Health on its USD 220 million fund raise led by Temasek and LGT Lightstone Aspada that included a partial exit for Everstone
Jan 2020

Value : USD 50 million

Avendus Capital advises Slayback Pharma LLC on its fundraise
Investment Banking
September 2020

Staffing for IT services: A perspective

Staffing industry makes a vital contribution to the economy and provides easy access to jobs and career opportunities. Historically, the global staffing industry has outpaced labor market growth and has grown by 5% CAGR between 2010 and 2018.

Read Time: 3 minutes
Investment Banking
January 2019

How India's services sector is a perfect springboard for automation

Voice recognition software monitors quality of interaction between humans and the external world and has the ability to escalate matters and intervene in real time. Gone are the days where supervisors walked the aisles to troubleshoot.

Read Time: 4 minutes
Investment Banking
February 2020

Investing in Affordable Housing companies: The next big wave

India has only touched the tip of the iceberg when it comes to affordable housing finance. For India to become a USD 5 trillion economy by 2025, ‘Housing for All’ is an important cog in the wheel.

Read Time: 2 minutes
Investment Banking
April 2020

AI and Analytics: Driving the Next Wave of Digital Transformation

Data and analytics are at the heart of digital transformation - the USD 27 billion offshore analytics market is expected to grow at 21.5% CAGR till 2025.

Read Time: 3 minutes
Investment Banking
July 2020

The Economics of Electric Vehicles in India

EVs are expensive than ICE vehicles. But their high capex cost is offset by their significantly lower opex cost. Thus, Total Cost of Ownership (TCO) is an important element of EV purchase decision. Do EVs make economic sense in India at present time?

Read Time: 5 minutes
Investment Banking
July 2019

The value in venture capital

India is going through one of its strongest funding cycles where founders are looking for more than just capital.

Read Time: 6 minutes
Investment Banking
January 2020

Developments in China aiding Indian Specialty Chemicals Industry

One of the most prominent trends in the global specialty chemicals industry over the last two decades has been the emergence of China as a key supplier in the specialty chemicals space.

Read Time: 6 minutes
Investment Banking
February 2020

Will Azure top AWS? Take a deep dive into the Azure Cloud Services ecosystem with Avendus’ latest report

Global businesses and organizations are continuing to invest in their technological evolution at an ever increasing rate.

Read Time: 5 minutes

Reports

Enterprise Technology & Services

Industrials

Get in touch

Connect with us on healthcare@avendus.com and we’ll get in touch with you.